Opalescence in Monoclonal Antibody Solutions and Its Correlation with Intermolecular Interactions in Dilute and Concentrated Solutions
- 1 April 2015
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 104 (4) , 1263-1274
Abstract
No abstract availableKeywords
Funding Information
- AbbVie
This publication has 40 references indexed in Scilit:
- The state of antibody therapyHuman Immunology, 2010
- Monoclonal antibodies — a proven and rapidly expanding therapeutic modality for human diseasesProtein & Cell, 2010
- Nature and consequences of protein–protein interactions in high protein concentration solutionsInternational Journal of Pharmaceutics, 2008
- Antibody Structure, Instability, and FormulationJournal of Pharmaceutical Sciences, 2007
- Formulation and delivery issues for monoclonal antibody therapeuticsAdvanced Drug Delivery Reviews, 2006
- Protein aggregation and its inhibition in biopharmaceuticsInternational Journal of Pharmaceutics, 2005
- Opalescent Appearance of an IgG1 Antibody at High Concentrations and Its Relationship to Noncovalent AssociationPharmaceutical Research, 2004
- Challenges in the development of high protein concentration formulationsJournal of Pharmaceutical Sciences, 2004
- Commercial manufacturing scale formulation and analytical characterization of therapeutic recombinant antibodiesDrug Development Research, 2004
- Macromolecular crowding: qualitative and semiquantitative successes, quantitative challengesBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2003